Publications by authors named "Robin A B Elferink"

Claim this Profile
D
Development of a stable inhalable dry powder formulation with osteoglycin fragment for alveolar epithelial repair.
Luke van der Koog, Evalyne M Jansen, Robin A B Elferink, Sophie I T Bos, Anika Nagelkerke

Int J Pharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Development of a stable inhalable dry powder formulation with osteoglycin fragment for alveolar epithelial repair" [Int. J. Pharm. 682 (2025) 125913].
Luke van der Koog, Evalyne M Jansen, Robin A B Elferink, Sophie I T Bos, Anika Nagelkerke

Int J Pharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast-derived osteoglycin promotes epithelial cell repair.
Luke van der Koog, Manon E Woest, Iris C Gorter, Vicky Verschut, Robin A B Elferink

NPJ Regen Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development.
Eva M Jansen, Luke van der Koog, Robin A B Elferink, Karim Rafie, Anika Nagelkerke

Small· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The soluble factor milieu in idiopathic pulmonary fibrosis dysregulates epithelial differentiation.
Rosa K Kortekaas, Kerstin E Geillinger-Kästle, Rocío Fuentes-Mateos, Anita Schönleber, Luke van der Koog, Robin A B Elferink

FASEB J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis